Accessibility Menu
Oncology Institute logo

Oncology Institute(NASDAQ) TOI

Market Cap$485.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-50%
5 Year-51%
1 Year+32%
1 Month-12%
$4.87
-4.04%
-0.20Today
After hours$4.86-$0.01 (-0.10%)
Oncology Institute last closing stock price
MetricPriceDate
Last closeUSD 4.862026-07-31
Oncology Institute stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.41%USD 4.982026-07-24
1 month-11.8%USD 5.512026-07-01
3 month+20%USD 4.052026-05-01
Year to date+36.52%USD 3.562025-12-31
1 year+32.43%USD 3.672025-07-31
3 year+362.86%USD 1.052023-08-01
5 year-51.06%USD 9.932021-07-30
Since inception-49.9%USD 9.702020-06-04

Oncology Institute Financials at a Glance

Market Cap

$485.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$545.76M

Net Income (TTM)

-$43.51M

EPS (TTM)

-$0.38

P/E Ratio

-12.95

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$4.87

Volume

1,005,358.171

Open

$5.10

Previous Close

$4.86

Daily Range

$4.86 - $5.25

52-Week Range

$2.32 - $6.67

Estimated Earnings Date

Aug 6, 2026

TOI News

Getty - surprised interested amazed wow glasses

A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish

Selena MaranjianNov 21, 2025
GettyImages-2223908328-1518x800-4a8ddb9

This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined

Lawrence Rothman, CFAOct 21, 2025
Foolcom-Featured.png

Oncology Institute Sales Jump 22 Percent

Motley Fool Markets TeamAug 13, 2025
featured-earnings-leadership-highlights.png

The Oncology Institute Q2 Revenue Surges

Motley Fool Markets TeamAug 13, 2025
GettyImages-592647720-601x370-8b7e932.jpg

Oncology Institute Delivers a Mixed Q3

Motley Fool Markets TeamNov 13, 2024

TOI: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncology Institute

The Oncology Institute helps adults and seniors manage cancer care. It provides doctor visits, cancer drugs, and support programs. Patients get treatment, medication, and help navigating complex health systems.

What’s in the TOI Toolbox?

  • Physician Services (47%): Cancer doctor visits, chemotherapy, and radiation for adult and senior patients.
  • Dispensary (52%): In-house pharmacy for oral and injectable cancer drugs, both in clinics and by mail.
  • Clinical Trials & Other (1%): Access to research studies, palliative care, and outpatient stem cell transplants.
  • Infusion Services: On-site delivery of cancer drugs through intravenous (IV) infusions.
  • Patient Support: Help with care coordination, insurance, and navigating treatment options.

Growth Moves: The TOI Expansion Playbook

  • Expanded to 66 clinics across five U.S. states by 2025.
  • Entered a profit-sharing partnership with Helios CR, Inc. for clinical trials in 2025.
  • Launched cost reduction initiatives in 2025, and announced plans to pilot AI for insurance approvals.
  • Raised $16.5 million in a private placement in March 2025.
  • Established an at-the-market equity offering facility for up to $15 million in 2025.

Why TOI Isn’t Just Another Clinic

TOI integrates direct cancer care with cost management for patients and insurers. Its in-house pharmacy and coordinated care model streamline treatment and reduce administrative hurdles. The company’s focus on value-based contracts and automation supports operational efficiency.

Five Things You Need to Know

  • Revenue was $120 million in Q2 2025, up 21.5% year-on-year.
  • Dispensary segment led with 52% of Q2 2025 revenue, up 40.8% year-on-year.
  • Operating loss improved to $11 million in Q2 2025, from $16 million in Q2 2024.
  • Net cash used in operations was $15 million for the first half of 2025, down from $32 million.
  • TOI had $30 million in cash and $86 million in debt as of June 2025.

Bottom Line

TOI has grown by expanding clinics, pharmacy services, and research partnerships. The company continues to adapt its model to balance growth and cost control.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

641

CEO

Daniel Virnich, MD, MBA

Website

www.theoncologyinstitute.com

Headquarters

Cerritos, CA 90703, US

TOI Financials

Key Financial Metrics (TTM)

Gross Margin

14.82%

Operating Margin

-5.99%

Net Income Margin

-7.97%

Return on Equity

326.77%

Return on Capital

-41.02%

Return on Assets

-25.87%

Earnings Yield

-7.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$485.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

99.98M

Volume

1.01M

Avg. Volume

1.92M

Financials (TTM)

Gross Profit

$80.89M

Operating Income

-$32.69M

EBITDA

-$29.23M

Operating Cash Flow

-$21.81M

Capital Expenditure

-$3.91M

Free Cash Flow

-$25.73M

Cash & ST Invst.

$30.28M

Total Debt

$104.86M

Oncology Institute Performance Analysis

Oncology Institute annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 252,483,00024.4%
20232023-12-31USD 324,239,00028.4%
20242024-12-31USD 393,412,00021.3%
20252025-12-31USD 502,729,00027.8%
Oncology Institute sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3014.7%
Q32025-09-3014.0%
Q42025-12-313.9%
Q12026-03-313.9%
Oncology Institute annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.2127.7%
20232023-12-31USD -0.92336.8%
20242024-12-31USD -0.71-23.3%
20252025-12-31USD -0.54-22.9%
Oncology Institute sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3028.6%
Q32025-09-306.7%
Q42025-12-3171.4%
Q12026-03-3150.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$147.44M

+41.2%

Gross Profit

$21.70M

+25.8%

Gross Margin

14.72%

N/A

Market Cap

$485.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$758.06K

N/A

Employees

641

N/A

Net Income

-$2.49M

+87.3%

EBITDA

$1.06M

+108.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$30.28M

-23.8%

Total Debt

$104.86M

+2.5%

Accounts Receivable

$59.45M

+19.7%

Inventory

$24.29M

+97.4%

Long Term Debt

$97.45M

+2.1%

Short Term Debt

$7.40M

+8.6%

Return on Assets

-25.87%

N/A

Return on Invested Capital

-36.77%

N/A

Free Cash Flow

-$3.26M

+38.7%

Operating Cash Flow

-$2.22M

+55.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KIDSOrthoPediatrics Corp.
$20.19+0.40%
CCRNCross Country Healthcare, Inc.
$13.25+0.00%
AUTLAutolus Therapeutics plc
$1.49-2.61%
EOLSEvolus, Inc.
$5.84-2.83%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About TOI

What is the current price of Oncology Institute?

Oncology Institute is trading at $4.86 per share.

What is the 52-week range for Oncology Institute?

Over the past 52 weeks, Oncology Institute has traded between $2.32 and $6.67.

How much debt does Oncology Institute have?

As of the most recent reporting period, Oncology Institute reported total debt of $104.86M.

How much cash does Oncology Institute have on hand?

Oncology Institute reported $30.28M in cash and cash equivalents in its most recent financial results.

What is Oncology Institute’s dividend yield?

Oncology Institute does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services